PubMed=10449618; DOI=10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F
Cheung S.-T., Huang D.P., Hui A.B.-Y., Lo K.-W., Ko C., Tsang Y.S., Wong N., Whitney B.M., Lee J.C.-K.
Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus.
Int. J. Cancer 83:121-126(1999)

PubMed=12645650; DOI=10.1016/S0165-4608(02)00657-X
Wong N., Hui A.B.-Y., Fan B.-L., Lo K.-W., Pang E., Leung S.-F., Huang D.P., Johnson P.J.
Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping.
Cancer Genet. Cytogenet. 140:124-132(2003)

PubMed=18196576; DOI=10.1002/ijc.23374
Chan S.Y.-Y., Choy K.-W., Tsao S.-W., Tao Q., Tang T., Chung G.T.-Y., Lo K.-W.
Authentication of nasopharyngeal carcinoma tumor lines.
Int. J. Cancer 122:2169-2171(2008)

PubMed=23915735; DOI=10.1186/1750-9378-8-29; PMCID=PMC3734220
Tso K.K.-Y., Yip K.Y.-L., Mak C.K.-Y., Chung G.T.-Y., Lee S.-D., Cheung S.-T., To K.-F., Lo K.-W.
Complete genomic sequence of Epstein-Barr virus in nasopharyngeal carcinoma cell line C666-1.
Infect. Agents Cancer 8:29.1-29.4(2013)

PubMed=24991015; DOI=10.1128/JVI.01457-14; PMCID=PMC4178894
Strong M.J., Baddoo M., Nanbo A., Xu M., Puetter A., Lin Z.
Comprehensive high-throughput RNA sequencing analysis reveals contamination of multiple nasopharyngeal carcinoma cell lines with HeLa cell genomes.
J. Virol. 88:10696-10704(2014)

PubMed=25787276; DOI=10.1128/JVI.03614-14; PMCID=PMC4442510
Palser A.L., Grayson N.E., White R.E., Corton C., Correia S., Ba Abdullah M.M., Watson S.J., Cotten M., Arrand J.R., Murray P.G., Allday M.J., Rickinson A.B., Young L.S., Farrell P.J., Kellam P.
Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection.
J. Virol. 89:5222-5237(2015)

PubMed=26116706; DOI=10.1096/fj.14-266718
Ye F., Chen C.-G., Qin J., Liu J., Zheng C.-Y.
Genetic profiling reveals an alarming rate of cross-contamination among human cell lines used in China.
FASEB J. 29:4268-4272(2015)

PubMed=30405107; DOI=10.1038/s41467-018-06889-5; PMCID=PMC6220246
Lin W.-T., Yip Y.-L., Jia L., Deng W., Zheng H., Dai W., Ko J.M.-Y., Lo K.-W., Chung G.T.-Y., Yip K.Y.-L., Lee S.-D., Kwan J.S.-H., Zhang J., Liu T.-F., Chan J.Y.-W., Kwong D.L.-W., Lee V.H.-F., Nicholls J.M., Busson P., Liu X.-F., Chiang A.K.-S., Hui K.-F., Kwok H., Cheung S.-T., Cheung Y.-C., Chan C.-K., Li B., Cheung A.L.-M., Hau P.-M., Zhou Y., Tsang C.-M., Middeldorp J.M., Chen H.-L., Lung M.L., Tsao S.-W.
Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma.
Nat. Commun. 9:4663.1-4663.17(2018)